Frequency, severity and duration of immune reconstitution events in HIV-related tuberculosis.
W. J. Burman(University of Colorado Health), Wafaa El‐Sadr(University of North Texas), Charllys Ribeiro Dias e Silva, Bonita T. Mangura(University of North Texas), Andrew Vernon(Centers for Disease Control and Prevention), B. King, Abdul Qadir Khan(Centers for Disease Control and Prevention), Chris Lahart(University of North Texas), Debra Benator(George Washington University), Brenda Jones(University of Southern California), Stephen E. Weis(University of North Texas), Marc Weiner(The University of Texas at San Antonio Health Science Center)
PubMed
December 1, 2007
Cited by 131
Related Papers
Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis
|Clinical Infectious Diseases|2016|1.5k
Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection - United States, 2010.
|PubMed|2010|1.1k
Guidelines for Using the QuantiFERON-TB Gold Test for Detecting Mycobacterium tuberculosis Infection, United States
|PsycEXTRA Dataset|2005|694
Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis
|New England Journal of Medicine|2021|548
Hidden Little Monsters: Spectroscopic Identification of Low-mass, Broad-line AGNs at z > 5 with CEERS
|The Astrophysical Journal Letters|2023|381